Paul Eckert resides in Doylestown, Pennsylvania, where he operates Family Financial Centers as its founder and CEO. The company stands out for holding an A+ rating with the Better Business Bureau. Outside of work, Paul Eckert is an avid fan of the Cleveland Browns. The Cleveland Browns are one of the oldest franchises of the National Football League, with many storied players having donned the uniform throughout the years. Names such as Jim Brown and Bernie Kosar often spring to mind in conversations about all-time great Browns, but there are other players who have made significant contributions, even though they are sometimes overlooked by the public. Clay Matthews, Jr., is one of them. For 16 seasons, Matthews was a mainstay on the Browns’ defense as a linebacker and defensive end. The fact that he lasted for so long in one of football’s most physically demanding positions is alone worthy of praise, but that he did so as a relatively undersized athlete makes the feat even more impressive. He lined up at nearly every linebacker position and racked up more than 1,400 tackles, 62 sacks, and 14 interceptions during his career in Cleveland.
With franchise industry experience spanning more than 25 years, Paul Eckert serves as the founder and owner of the Eckert Group as well as the president and chief executive officer of Family Financial Centers, LLC, both based in Doylestown, Pennsylvania. Outside of his professional life, Paul Eckert is a longtime supporter of the Children’s Hospital of Philadelphia (CHOP). Researchers at CHOP recently announced a breakthrough in understanding the way the immune system communicates when faced with fighting infections or cancer. Kai Tan, PhD, who served as a coleader in the study, said that his team has developed tools to locate the specific molecular pathways and other signaling paths that CD8+ T cells - vital immune system cells - utilize in response to these conditions.In their trials, researchers studied laboratory mice and how their immune cells responded to certain infections. Using state-of-the-art biometric tools and techniques, the team found increased activity in the CD8+ T cells in their responses to invading forces, such as infections and cancer. This discovery, the researchers say, will help pave the way for more breakthroughs in the study of immunology and oncology. Funding for the research was provided through a grant from the National Institutes of Health.
